MYC and hepatocellular carcinoma: Recent results from liver cancer mouse models suggest that high p62 expression exerts its oncogenic activity via Nrf2, mTORC1, and c-Myc activation, and hepatocyte-specific deletion of p62 impairs hepatocellular carcinoma (HCC) formation (Umemura et al., 2016).